Literature DB >> 28578004

Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.

Irene Sebastianutto1, Maria Angela Cenci1, Tim Fieblinger2.   

Abstract

Striatal neurons forming the indirect pathway (iSPNs) are particularly vulnerable in Huntington's disease (HD). In this study we set out to investigate morphological and physiological alterations of iSPNs in two mouse models of HD with relatively slow disease progression (long CAG repeat R6/2 and zQ175-KI). Both were crossed with a transgenic mouse line expressing eGFP in iSPNs. Using the open-field and rotarod tests, we first defined two time points in relation to the occurrence of motor deficits in each model. Then, we investigated electrophysiological and morphological properties of iSPNs at both ages. Both HD models exhibited increased iSPN excitability already before the onset of motor deficits, associated with a reduced number of primary dendrites and decreased function of Kir- and voltage-gated potassium channels. Alterations that specifically occurred at symptomatic ages included increased calcium release by back-propagating action potentials in proximal dendrites, due to enhanced engagement of intracellular calcium stores. Moreover, motorically impaired mice of both HD models showed a reduction in iSPN spine density and progressive formation of huntingtin (Htt) aggregates in the striatum. Our study therefore reports iSPN-specific alterations relative to the development of a motor phenotype in two different mouse models of HD. While some alterations occur early and are partly non-progressive, others potentially provide a pathophysiological marker of an overt disease state.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium; Dendrites; Excitability; Huntington's disease; Indirect pathway; Patch clamp; Striatum; Two photon

Mesh:

Substances:

Year:  2017        PMID: 28578004     DOI: 10.1016/j.nbd.2017.05.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  15 in total

1.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

2.  Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.

Authors:  Xiong Yang; Shi-Feng Chu; Zhen-Zhen Wang; Fang-Fang Li; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

3.  Synaptic Dysfunction in Huntington's Disease: Lessons from Genetic Animal Models.

Authors:  Carlos Cepeda; Michael S Levine
Journal:  Neuroscientist       Date:  2020-11-16       Impact factor: 7.235

Review 4.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

5.  Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington's disease.

Authors:  Dika Kuljis; Takashi Kudo; Yu Tahara; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2018-08-31       Impact factor: 4.164

6.  Dysregulation of the Basal Ganglia Indirect Pathway in Early Symptomatic Q175 Huntington's Disease Mice.

Authors:  Joshua W Callahan; David L Wokosin; Mark D Bevan
Journal:  J Neurosci       Date:  2022-01-20       Impact factor: 6.709

7.  Differential changes to D1 and D2 medium spiny neurons in the 12-month-old Q175+/- mouse model of Huntington's Disease.

Authors:  Joseph W Goodliffe; Hanbing Song; Anastasia Rubakovic; Wayne Chang; Maria Medalla; Christina M Weaver; Jennifer I Luebke
Journal:  PLoS One       Date:  2018-08-17       Impact factor: 3.240

8.  Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.

Authors:  Yunping Deng; Hongbing Wang; Marion Joni; Radhika Sekhri; Anton Reiner
Journal:  J Comp Neurol       Date:  2020-09-20       Impact factor: 3.215

9.  Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats.

Authors:  T Fieblinger; L Zanetti; I Sebastianutto; L S Breger; L Quintino; M Lockowandt; C Lundberg; M A Cenci
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

10.  Impaired Performance of the Q175 Mouse Model of Huntington's Disease in the Touch Screen Paired Associates Learning Task.

Authors:  Tuukka O Piiponniemi; Teija Parkkari; Taneli Heikkinen; Jukka Puoliväli; Larry C Park; Roger Cachope; Maksym V Kopanitsa
Journal:  Front Behav Neurosci       Date:  2018-10-02       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.